Unfortunately, metastatic ccRCC, due to its high expression of multidrug resistance protein 1 (MDR-1), doesn’t respond to conventional chemotherapy, resulting in increased mortality1,4. This evidence concerns the gene ABCB1 and nonpapillary renal cell carcinoma.